Wednesday, July 8, 2026

pharma · ETON

Eton Pharmaceuticals

Eton Pharmaceuticals is a pharma organization headquartered in DEER PARK, IL, USA. It trades on NYSE under ticker ETON. NovaPharmaNews links 0 clinical program(s), 3 drug profile(s), and 163 patent record(s) to this enti

DEER PARK, IL, USA HQ
Public company Type
ETON · NYSE Ticker
Company details
Status
Public
HQ
DEER PARK, IL, USA
Programs
0
Drugs
3
Patents
163

Quick answer

Eton Pharmaceuticals is a pharma organization headquartered in DEER PARK, IL, USA. It trades on NYSE under ticker ETON. NovaPharmaNews links 0 clinical program(s), 3 drug profile(s), and 163 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

Company snapshot

Eton Pharmaceuticals is a pharma organization headquartered in DEER PARK, IL, USA. It trades on NYSE under ticker ETON. NovaPharmaNews links 0 clinical program(s), 3 drug profile(s), and 163 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

  • 4 approved product(s) across US/EU regulatory metadata.
  • 163 US patent(s) indexed to this assignee profile.

Public regulatory, clinical, patent, and corporate records for Eton Pharmaceuticals. Not investment advice.

Top assets

Lead pipeline drugs

Momentum

Proprietary activity score for Eton Pharmaceuticals.

0 /100 +0 vs 30 days ago

Signal breakdown

  • Clinical trials 0 30d
  • Nova articles 0 30d
  • Patents filed 0 30d
  • FDA actions 0 30d
  • SEC filings 0 30d
  • Conference presentations 0 90d
  • Pipeline advances 0 30d

Recent activity

Latest pipeline, patent, and corporate events for Eton Pharmaceuticals.

  1. Patent grant

    Hydrocortisone oral liquid formulations

  2. Patent grant

    Ketone ester as a therapeutic treatment of Covid-19 and related viral infections

  3. Patent grant

    Hydrophobic ion pairing and flash nanoprecipitation for formation of controlled-release nanocarrier formulations

  4. Patent grant

    Dihydromyricetin hot melt extrusion formulations and methods for forming them

  5. Patent grant

    Immunotherapy with metabolic enzyme expression

View all clinical trial activity →

Quick answers

Common questions about this sponsor — for analysts and search.

  • What is Eton Pharmaceuticals?

    Eton Pharmaceuticals is a pharma organization headquartered in DEER PARK, IL, USA. It trades on NYSE under ticker ETON. NovaPharmaNews links 0 clinical program(s), 3 drug profile(s), and 163 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sourc

  • Is Eton Pharmaceuticals publicly traded?

    Yes. Eton Pharmaceuticals is listed with ticker ETON on NYSE per SEC EDGAR records linked on this profile.

  • What drugs does Eton Pharmaceuticals develop or market?

    We link 3 drug profile(s) where Eton Pharmaceuticals is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/eton-pharmaceuticals#company-drugs.

  • What are the latest developments for Eton Pharmaceuticals?

    In the last 12 months our linked public records show 0 trial program update(s) and 5 US patent grant(s) tied to this profile.

  • What therapeutic areas does Eton Pharmaceuticals focus on?

    No specific therapeutic focus areas are currently identified for Eton Pharmaceuticals in our database.

Therapeutic focus

Therapeutic area distribution

Pipeline concentration by therapeutic area from linked clinical programs.

Programs by therapeutic area

Others
1